|
N/A
|
N01CA700006
|
$2,299,478
|
|
N/A
|
WESTAT, INC.
|
|
N/A
|
N01CA800018
|
$46,530
|
|
N/A
|
NOVA RESEARCH COMPANY
|
|
TAS::75 0849::TAS PROJECT TITLE:GENETIC AND EPIDEMIOLOGICAL STATISTICAL ANALYSIS
|
N02CA190389
|
$24,425
|
|
N/A
|
DUKE UNIVERSITY
|
|
Research Management and Support
|
RMS ES 2017
|
$326,124,631
|
$1,816,148
|
N/A
|
National Institutes of Health
|
|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
$2,400
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S2
|
$60,000
|
$1,200
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S3
|
$118,652
|
$2,373
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S4
|
$199,541
|
$3,991
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-43
|
$3,792,720
|
$75,854
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer screening among Latinas
|
5R21CA134247-02
|
$212,520
|
|
ABRAIDO-LANZA, ANA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Using Email to Enhance Counseling Services at NCI's Smoking Cessation Quitline
|
5K07CA124579-03
|
$134,528
|
|
ABROMS, LORIEN
|
GEORGE WASHINGTON UNIVERSITY
|
|
Gene-environment EBV Interactions in the Etiology of Nasopharyngeal Carcinoma (NP
|
5R01CA115873-03
|
$1
|
|
ADAMI, HANS-OLOV
|
HARVARD UNIVERSITY (SCH OF PUBLIC HLTH)
|
|
Discovery and Characterization of Mutations in Breast and Ovarian Cancers
|
5R50CA211280-02
|
$215,047
|
$107,524
|
ADAMSON, AARON
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
MRI for In Vivo Quantification of Yttrium-90 Microsphere Biodistribution
|
1F31CA150658-01
|
$31,692
|
|
Adeyanju, Oyinlolu
|
NORTHWESTERN UNIVERSITY
|
|
Identifying the Drivers and Targeting Chemo Resistance in Ovarian Cancer
|
1R01CA211648-01A1
|
$429,211
|
$429,211
|
ADLI, MAZHAR
|
UNIVERSITY OF VIRGINIA
|
|
MMC, VICC & TSU: Partners in Eliminating Cancer Disparities (1 of 3)
|
5U54CA163069-07
|
$1,414,315
|
$70,716
|
ADUNYAH, SAMUEL
|
MEHARRY MEDICAL COLLEGE
|
|
Platelets promote growth of ovarian cancer
|
5R01CA177909-05
|
$332,000
|
$332,000
|
AFSHAR-KHARGHAN, VAHID
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Skin Cancer Chemoprevention by Silibinin: Mechanisms and Efficacy
|
1R01CA140368-01A1
|
$313,408
|
|
AGARWAL, RAJESH
|
UNIVERSITY OF COLORADO DENVER
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
3U10CA180791-03S1
|
$154,939
|
$3,099
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Network Lead Academic Participating Site: Memorial Sloan-Kettering Cancer Center
|
5U10CA180791-04
|
$737,200
|
$14,744
|
AGHAJANIAN, CAROL
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
A MicroRNA Approach to Screen for Sporadic Colon Cancer Exfoliately in Human Stoo
|
1R43CA144823-01A1
|
$402,336
|
|
Ahmed, Farid
|
GEM TOX CONSULTANTS AND LABS, INC.
|
|
Chemoprevention of arsenic-induced skin cancer
|
2R01CA107431-06
|
$2,003,032
|
|
AHSAN, HABIBUL
|
UNIVERSITY OF CHICAGO
|
|
Genomewide association in early-onset breast cancer
|
5U01CA122171-05
|
$754,460
|
|
AHSAN, HABIBUL
|
UNIVERSITY OF CHICAGO
|
|
Epigenetic markers involved in colorectal cancer recurrence and metastases
|
5K23CA127141-03
|
$140,940
|
|
AHUJA, NITA
|
JOHNS HOPKINS UNIVERSITY
|
|
Nucleotide Metabolism in Senescence and Platinum Resistance of Ovarian Cancer
|
4R00CA194309-03
|
$249,000
|
$249,000
|
AIRD, KATHERINE
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Biodegradable Polymeric Nanosphere Drug Delivery System For Cancer Chemotherapy
|
5SC2CA138179-03
|
|
|
AKALA, EMMANUEL
|
HOWARD UNIVERSITY
|
|
Treatment of Osteoradionecrosis with Bone Marrow Stromal Cells
|
5K08CA120875-05
|
$138,381
|
|
AKINTOYE, SUNDAY
|
UNIVERSITY OF PENNSYLVANIA
|
|
North Carolina A&T University-Wake Forest Cancer Center partnership (2 of 2)
|
5P20CA138018-03
|
$132,788
|
|
AKMAN, STEVEN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Naional Cancer Institute, Naitonal Clinical Trials Network U10 Lead Academic Site
|
5U10CA180790-04
|
$1,367,856
|
$27,357
|
ALBERTS, STEVEN
|
MAYO CLINIC ROCHESTER
|
|
Amplicons in Oral Dysplasia
|
5R01CA131286-03
|
$270,000
|
|
Albertson, Donna
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Assessments of Multiple Breast Cancer Biomarkers with Dendritic MRI Probes
|
5K25CA129173-02
|
$128,715
|
|
Ali, Md
|
HENRY FORD HEALTH SYSTEM
|
|
Targeting defective DNA repair for the prevention of BRCA1-associated cancers
|
5K22CA181550-03
|
$162,000
|
$81,000
|
ALLI, ELIZABETH
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Multi-Tensor Decompositions for Personalized Cancer Diagnostics and Prognostics
|
5U01CA202144-03
|
$704,509
|
$352,255
|
ALTER, ORLY
|
UNIVERSITY OF UTAH
|
|
Inherited bone marrow failure syndromes study
|
ZIA CP010144 07130
|
$1,589,054
|
|
Alter, Blanche
|
DCEG (NCI)
|
|
Consolidated Basic Cancer Research Program
|
3P30CA010815-48S1
|
$142,498
|
$15,675
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Consolidated Basic Cancer Research Program
|
5P30CA010815-48
|
$2,645,581
|
$291,014
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Exploiting altered glucose utilization in Bcr-Abl+ Leukemia
|
1F31CA157166-01
|
$28,740
|
|
Alvarez-Calderon, Francesca
|
UNIVERSITY OF COLORADO DENVER
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$755,842
|
$37,792
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Image-Guided Stereotactic Radiosurgery of Breast Cancer
|
5R44CA132254-04
|
$1,000,000
|
|
Amies, Christopher
|
XCISION MEDICAL SYSTEMS, LLC
|
|
COMBINATORIAL-DESIGNED NANO-PLATFORMS TO OVERCOME TUMOR DRUG RESISTANCE
|
1U01CA151452-01
|
$482,687
|
$241,344
|
AMIJI, MANSOOR
|
NORTHEASTERN UNIVERSITY
|
|
Dietary Prevention of Cancer
|
3R01CA109269-07S1
|
$81,290
|
|
ANANT, SHRIKANT
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
Dietary Prevention of Cancer
|
5R01CA109269-07
|
$283,480
|
|
ANANT, SHRIKANT
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
|
A biobehavioral intervention for patients with breast cancer recurrence
|
5R21CA135005-02
|
$198,000
|
|
Andersen, Barbara
|
OHIO STATE UNIVERSITY
|
|
The University of Kentucky Cancer Nanotechnology Training Center (UK CNTC)
|
1R25CA153954-01
|
$335,580
|
$67,116
|
Anderson, Bradley
|
UNIVERSITY OF KENTUCKY
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S1
|
$56,922
|
$9,108
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-05S2
|
$165,708
|
$26,513
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Women's Health Initiative Cancer Survivor Cohort
|
5UM1CA173642-05
|
$2,260,718
|
$361,715
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Nuclear Factor-kappaB in Ovarian Cancer
|
ZIA BC 011054
|
$515,250
|
$515,250
|
Annunziata, Christina
|
CCR (NCI)
|
|
Clinical trials in women's cancers
|
ZIA BC 011584
|
$206,100
|
$144,270
|
Annunziata, Christina
|
CCR (NCI)
|
|
Immune cell control of ovarian cancer
|
ZIA BC 011775
|
$309,150
|
$309,150
|
Annunziata, Christina
|
CCR (NCI)
|
Total relevant funding to Ovarian Cancer for this search: $125,010,035
|